Studies reported that TRIB3 promotes acute promyelocytic leukemia by stabilizing oncoprotein PML-RAR α and inhibiting p53-mediated aging (Li K. et al., 2017). This evidence concerns the gene TP53 and acute promyelocytic leukemia.